Indo US Bio-TechNSE:INDOUS -0.27%63 EBITDA Margin % is 12.49% as of Mar. 2026, which is 8% below its 10-year median of 13.52. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹198.40 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 251 Agriculture companies, Indo US Bio-Tech ranks better than 74.5% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Indo US Bio-Tech's EBITDA for the
three
months ended in Mar. 2026 was ₹32 Mil. Indo US Bio-Tech's Revenue for the
three
months ended in Mar. 2026 was ₹260 Mil. Therefore, Indo US Bio-Tech's EBITDA margin for the quarter that ended in Mar. 2026 was 12.49%.
Indo US Bio-Tech (NSE:INDOUS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Indo US Bio-Tech EBITDA Margin % Related Terms
Indo US Bio-Tech EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (NSE:INDOUS) has a EBITDA Margin % of 12.49% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Indo US Bio-Tech and its competitors. This is near median its historical median of 13.52. Over the past decade, Indo US Bio-Tech's EBITDA Margin % has ranged from 5.26 to 18.41. According to the industry distribution chart, Indo US Bio-Tech ranks #64 out of 251 companies in the Agriculture industry, placing it in the top 25.5%.
Is Indo US Bio-Tech's EBITDA Margin % too high?
Indo US Bio-Tech's current EBITDA Margin % of 12.49% is near median its 10-year median of 13.52. Over the past 10 years, this metric has ranged from a low of 5.26 to a high of 18.41. The Agriculture industry median EBITDA Margin % is 9.60. Indo US Bio-Tech's value of 12.49% is 30.1% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #64 out of 251 companies in the Agriculture industry, which is above the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #64 out of 251 companies for EBITDA Margin %. This puts Indo US Bio-Tech in the upper half of its industry. The industry median EBITDA Margin % is 9.60. Indo US Bio-Tech's value of 12.49% is 30.1% above this benchmark. Historically, Indo US Bio-Tech's own EBITDA Margin % has ranged from 5.26 to 18.41 over the past decade. While the company's 10-year median is 13.52 vs. the industry median of 9.60, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.60, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current EBITDA Margin % of 12.49% is 30.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current EBITDA Margin % is 12.49%, which is near median its own 10-year median of 13.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.40, compared to a current price of ₹88.75 — trading 55.3% below its estimated fair value. The current EBITDA Margin % is 12.49%, which is near median its 10-year median of 13.52 and 30.1% above the Agriculture industry median of 9.60. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current EBITDA Margin % is 12.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.75 is trading 55.3% below its estimated GF Value™ of ₹198.40.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
EBITDA Margin %: 12.49% (near median its 10-year median of 13.52)
GF Value™: ₹198.40 vs. price of ₹88.75 (55.3% below fair value)
Industry Position: 30.1% above the Agriculture median (#64 of 251)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
